Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

NSE/HALEOSLABS stock hub

NSE/HALEOSLABS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/HALEOSLABSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/HALEOSLABS

In the news

Latest news · NSE/HALEOSLABS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E25

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC8

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/HALEOSLABS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

188

Groups with data

Currency

INR

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	592
Employees Change	18%
Employees Change Percent	3.14
Enterprise value	INR 5.8B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Biotechnology
Isin	INE320X01016
Last refreshed	2026-05-10
Market cap	INR 5B
Price	INR 1,675
Price currency	INR
Rev Per Employee	5,874,456.08x
Sector	Healthcare
Sic	2834
Symbol	nse/HALEOSLABS
Website	https://haleoslabs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4%
EV Earnings	29.28x
EV/EBIT	18.44x
EV/EBITDA	12.49x
EV/Sales	1.67x
P/B ratio	2.23x
P/E ratio	25.03x
P/S ratio	1.43x
PE Ratio10 Y	14.96x
PE Ratio3 Y	21.01x
PE Ratio5 Y	16.95x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	9.06%
EBITDA Margin	13.2%
Gross margin	37.15%
Gross Profit	INR 1.3B
Gross Profit Growth	6.52%
Gross Profit Growth Q	7.04%
Gross Profit Growth3 Y	12.66%
Gross Profit Growth5 Y	14.17%
Net Income	INR 198.5M
Net Income Growth	-13.85%
Net Income Growth Q	21.07%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Net Income Growth3 Y	1.72%
Net Income Growth5 Y	13.4%
Pretax Margin	8.11%
Profit Margin	5.71%
Profit Per Employee	INR 335,289
Profitable Years	9
Roa5y	4.03
Roe5y	9.45
ROIC	8.05
Roic5y	6.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	39.08%
Cagr3y	46.41%
Cagr5y	23.48%
Div CAGR3	0%
Div CAGR5	0%
EPS Growth	-13.83
EPS Growth Q	21.07
EPS Growth Quarters	1
EPS Growth Years	1
EPS Growth3 Y	1.72
EPS Growth5 Y	13.4
Revenue Growth	0.63x
Revenue Growth Q	12.04x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	0.03x
Revenue Growth5 Y	8.71x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 15.7M
Debt	INR 697.9M
Debt EBITDA	INR 1.5
Debt Equity	INR 0.31
Equity	INR 2.2B
Interest Coverage	4.63
Net Cash	INR -682.2M
Net Cash By Market Cap	INR -13.73
Net Debt EBITDA	INR 1.49
Net Debt Equity	INR 0.31
Tangible Book Value	INR 2.1B
Tangible Book Value Per Share	INR 683
WACC	6.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.02%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 1.5
Dividend Years	5
Dividend Yield	0.09%
Ex Div Date	2025-09-24
Last Dividend	INR 1.5
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	39.05%
200-day SMA	1,247.2
3Y total return	213.91%
50-day SMA	1,321.5
50-day SMA vs 200-day SMA	50over200
5Y total return	186.99%
All Time High	1,749.7
All Time High Change	-4.27%
All Time High Date	2024-09-09
All Time Low	128.5
All Time Low Change	1,204.01%
All Time Low Date	2017-08-17
ATR	75.84
Beta	0.32
Beta1y	0.49
Beta2y	0.25
Ch YTD	26.51
High	1,679
High52	1,679
High52 Date	2026-05-08
High52ch	0%
Low	1,570
Low52	1,067
Low52 Date	2025-08-13
Low52ch	56.98%
Ma50ch	26.75%
Price vs 200-day SMA	34.3%
RSI	75.56
RSI Monthly	68.33
RSI Weekly	72.88
Sharpe ratio	0.57x
Sortino ratio	1.09
Total Return	0.11%
Tr YTD	26.51
Tr1m	30%
Tr1w	10.65%
Tr3m	31.89%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 315.2M
Operating Income Growth	-7.57
Operating Income Growth Q	12.68
Operating Income Growth3 Y	9.86
Operating Income Growth5 Y	12.19
Operating margin	9.06

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	756,039%
Shares Insiders	72.97%
Shares Out	3,023,287
Shares Qo Q	0.01%
Shares Yo Y	-0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	2,428.8x
Bv Per Share	682.9
Ch1m	30
Ch1w	10.65
Ch1y	38.88
Ch3m	31.89
Ch3y	212.3
Ch5y	184.3
Ch6m	43.04
Change	3.65%
Change From Open	3.65
Close	1,616
Days Gap	0
Depreciation Amortization	143,936,500
Dollar Volume	4,448,800
Earnings Date	2026-05-26
EBIT	INR 315.2M
EBITDA	INR 459.1M
EPS	INR 65.65
F Score	2
Fiscal Year End	March
Founded	1,990
Graham Number	1004.39769
Graham Upside	-40.04
Income Tax	INR 72.8M
Is Primary Listing	1
Last Earnings Date	2026-02-11
Last Report Date	2025-12-31
Lynch Fair Value	INR 880
Lynch Upside	-47.48
Ma150	1,275.7
Ma150ch	31.3%
Ma20	1,403.3
Ma20ch	19.36%
Next Earnings Date	2026-05-26
Open	1,616
Payment Date	2025-10-30
Position In Range	96.33
Price Date	2026-05-08
Price EBITDA	INR 10.82
Ptbv Ratio	2.41
Relative Volume	1.13x
Revenue	3,477,678,000x
Tax By Revenue	2.09x
Tax Rate	25.8%
Tr6m	43.04%
Volume	2,656

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/HALEOSLABS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.1%

$1.50 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

0 consecutive years of growth

Total shareholder yield

+0.1%

Next ex-dividend date: 2025-09-24

Performance

NSE/HALEOSLABS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/HALEOSLABS?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+73.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

NSE/HALEOSLABS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

75.6

Above 70: short-term overbought

Price vs 200-day MA

+34.3%

50/200-day relationship not available

Beta (5Y)

0.32

Less volatile than the market

Sharpe ratio

0.57

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/HALEOSLABS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/HALEOSLABS stock rating?

nse/HALEOSLABS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/HALEOSLABS analysis?

The full report lives at /stocks/nse/HALEOSLABS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/HALEOSLABS?

The latest report frames nse/HALEOSLABS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/HALEOSLABS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.